ENVALITH
株式会社I-ne logo

I-ne Co., Ltd.

4933Prime MarketChemicals

株式会社I-ne logo
I-ne Co., Ltd.4933

Business

I-ne Co., Ltd., founded in 2007, is a beauty brand company that focuses on BOTANIST (hair care), YOLU (night care), and SALONIA (beauty electronics), while also actively expanding into skincare brands such as WrinkFade and TOUT VERT (Tout Vert), as well as new categories including Teaflex (functional tea) and ReWEAR (regenerating fabric softener). Manufacturing is outsourced, with the company itself specializing in brand development, marketing, and sales. It employs an OMO strategy combining domestic wholesale (Arata, Ohki, etc.) with direct-to-consumer e-commerce (D2C), with its main customer base being beauty-conscious women in their 30s. Consolidated net sales for FY2025 (ending December 2025) were ¥48,975 million, with the Domestic Business accounting for over 97% of the total. The company is listed on the Prime Market of the Tokyo Stock Exchange.

Business Model

Using the proprietary IPTOS (Idea→Plan→Test→Online/Offline→Scale) model, the company develops full-scale rollouts of products that capture market needs early, validating them in stages. The structure involves confirming consumer response through direct e-commerce sales before expanding distribution to retailers and mass merchandisers nationwide via wholesalers. Manufacturing is outsourced, which keeps fixed costs down, while investment in advertising and sales promotion builds brand awareness and drives sales growth. A distinctive feature is the disciplined brand management approach, which sets withdrawal criteria to minimize losses from unprofitable brands.

Company Strengths

The company has built a proprietary IPTOS model that verifies the process in stages, from idea generation through small-lot test sales to full-scale rollout. In FY2025 (ending December 2025) alone, it launched multiple new brands in succession—Teaflex (February), ReWEAR (April), Befas (July), and Collatein (August)—each of which achieved either substantial growth or early sell-out.

In FY2025 (ending December 2025), sales composition was spread across four categories: YOLU at 31%, BOTANIST at 26%, SALONIA at 20%, and skincare and other at 23%. YOLU ranks second and BOTANIST ranks fourth in the domestic drugstore shampoo and treatment market (both based on sales value from January to December 2025, according to the company's own research), demonstrating that multiple brands have established solid market positions.

The company has built an OMO framework that combines a nationwide retail distribution network—with Arata Corporation (¥14,542 million in sales in FY2025 (ending December 2025), a 29.7% share) and Oki Corporation (¥5,073 million, a 10.4% share) as its main wholesale partners—with direct-to-consumer online channels including its own e-commerce site, Rakuten, and Amazon. Offline expansion also continues, as seen with TOUT VERT (Tout Vert), which began distribution to Loft stores nationwide starting in May 2025.

ENVALITH's Perspective

For FY2026 (ending December 2026), the earnings forecast discloses a range of net sales of ¥52,000-54,000 million (up 6.2-10.3% year on year), while operating income is projected in a range of ¥(500)-1,000 million. The main driver is a large-scale strategic additional investment of approximately ¥3,000 million aimed at mid-to-long-term growth, and the investment payback period and the timeline for profitability recovery are at the core of the investment decision. Geopolitical risk surrounding the Strait of Hormuz is also explicitly noted as having an uncertain impact on business performance, indicating a high degree of uncertainty.

Against Domestic segment profit of ¥7,298 million in FY2025 (ending December 2025), consolidated operating income after allocation of company-wide costs stood at ¥3,880 million (down 14.4% year on year). Company-wide costs (unallocated SG&A) increased by ¥635 million to ¥3,292 million from ¥2,657 million in the prior period, making clear a structural pattern in which the expansion of fixed costs such as head office functions and marketing is weighing down consolidated margins. As FY2026 (ending December 2026) will see the addition of a large-scale investment, this divergence is expected to widen further.

In February 2026, a special investigation committee was established, and it was determined that a restatement of the related-party notes concerning transactions with Right Here, a company established by a former employee, was necessary for prior periods. The investigation report was received in April 2026, and the company plans to restate the consolidated financial statements and other items in previously filed securities reports. Investigation and restatement-related expenses of ¥178 million are scheduled to be recorded in FY2026 (ending December 2026) (the final amount is subject to change). While the direct impact on financial figures appears limited, market assessment of the reliability of the internal control and governance framework will be closely watched.

Growth Strategy

Deepening penetration in haircare and beauty appliances, establishing skincare as a third pillar, overseas expansion, and a large-scale strategic investment of approximately ¥3,000 million

Continuing to expand sales of existing brands through the renewal of BOTANIST body soap, the launch of the fourth installment of the YOLU haircare series, and the expansion of SALONIA's mid-to-high price range products. Domestic Business sales for FY2025 (ending December 2025) reached ¥47,736 million (up 9.3% year on year), demonstrating steady growth.

Skincare brands such as TOUT VERT (Tout Vert) and Wrinkfade are performing well. Expansion into new categories such as ReWEAR (regenerated fabric softener) and Teaflex (functional tea) has also achieved significant growth, with skincare and other categories driving overall company growth. In FY2026 (ending December 2026), the company plans to further cultivate this area with a large-scale investment of approximately ¥3,000 million.

Liquidation procedures for the Chinese subsidiary (Aien (Shanghai) Cosmetics Co., Ltd.) began in December 2024, and in exchange for a decline in sales in the China region, operating loss improved significantly from ¥743 million to ¥125 million. The company is rebuilding its earnings base by continuing distribution in Asian regions such as Hong Kong, Taiwan, Singapore, Malaysia, and South Korea.

In FY2026 (ending December 2026), the company plans to make an additional large-scale strategic investment of approximately ¥3,000 million aimed at medium- to long-term growth. It will pursue both the cultivation of businesses that will become new growth pillars and the expansion of global business in parallel. The company states that details of the investment will be determined flexibly, and specific measures have not been disclosed.

Last updated: July 19, 2026